Feasibility of six cycles of lenalidomide-based triplet induction before stem cell collection for newly diagnosed transplant-eligible multiple myeloma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Feasibility of six cycles of lenalidomide-based triplet induction before stem cell collection for newly diagnosed transplant-eligible multiple myeloma

Published:2021-01-01 Issue:1 Volume:26 Page:388-392
ISSN:1607-8454
Container-title:Hematology
language:en
Short-container-title:Hematology

Author:

Yoshihara Satoshi¹²^ORCID,Yoshihara Kyoko¹,Shimizu Yoshifumi³,Imado Takehito³,Takatsuka Hiroyuki⁴,Kawamoto Hiroyuki⁵,Misawa Mahito⁶,Ifuku Hideki⁴,Ohe Yokiko⁵,Okada Masaya¹,Fujimori Yoshihiro¹²⁵

Affiliation:

1. Department of Hematology, Hyogo College of Medicine Hospital, Hyogo, Japan

2. Department of Transfusion Medicine and Cellular Therapy, Hyogo College of Medicine Hospital, Hyogo, Japan

3. Department of Hematology, Takarazuka City Hospital, Hyogo, Japan

4. Department of Hematology, Amagasaki Chuo Hospital, Hyogo, Japan

5. Department of Hematology, Uegahara Hospital, Hyogo, Japan

6. Department of Hematology, Ako Central Hospital, Hyogo, Japan

Funder

MEXT KAKENHI

Ministry of Education, Culture, Sports, Science and Technology

Publisher

Informa UK Limited

Subject

Hematology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/16078454.2021.1926101

Reference19 articles.

1. Complete response correlates with long-term survival and progression-free survival in high-dose therapy in multiple myeloma

2. Achievement of at Least Very Good Partial Response Is a Simple and Robust Prognostic Factor in Patients With Multiple Myeloma Treated With High-Dose Therapy: Long-Term Analysis of the IFM 99-02 and 99-04 Trials

3. Front-Line Transplantation Program With Lenalidomide, Bortezomib, and Dexamethasone Combination As Induction and Consolidation Followed by Lenalidomide Maintenance in Patients With Multiple Myeloma: A Phase II Study by the Intergroupe Francophone du Myélome

4. Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma

5. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive factors for peripheral blood stem cell mobilization in multiple myeloma in the era of novel therapies: A single‐center experience;Cancer Medicine;2024-06

2. Optimal approach to stem cell mobilization in transplant-eligible multiple myeloma patients;Journal of Cancer Metastasis and Treatment;2024-05-27

3. Myeloma Spine and Bone Damage Score (MSBDS) on Whole-Body Computed Tomography (WBCT): Multiple Reader Agreement in a Multicenter Reliability Study;Diagnostics;2022-08-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3